首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷核子醫學

市場調查報告書

商品編碼

1812405

核子醫學軟體市場按類型、模式、治療領域、部署模型、整合複雜性、定價模式、最終用戶和地區分類

Nuclear Medicine Software Market, By Type, By Modality, By Therapeutic Area, By Deployment Model, By Integration Complexity, By Pricing Model, By End User, By Geography

出版日期: 2025年08月22日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

核醫軟體市場預計在 2025 年價值 9.805 億美元，預計到 2032 年將達到 18.039 億美元，2025 年至 2032 年的複合年成長率為 9.1%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	9.805億美元
效能數據	2020-2024	預測期	2020-2024
預測期間（2025-2032年）的複合年成長率：	9.10%	2032年預測	18.039億美元

全球核子醫學軟體市場是支撐快速發展的核子醫學和分子影像領域的關鍵技術支柱。這類專業軟體涵蓋全面的解決方案，旨在促進核子醫學影像資料的收集、處理、分析和管理，包括 SPECT、PET 和混合顯像模式。

核子醫學軟體在提高診斷準確性、簡化工作流程和支援全球醫療機構的臨床決策方面發揮著至關重要的作用。該市場涵蓋各種軟體類別，例如影像重建軟體、定量分析工具、彙報系統和綜合醫院資訊管理平台。

隨著醫療保健系統日益重視精準醫療和個人化治療方法，核醫軟體已成為實現先進分子成像技術和放射性藥物應用的基礎組件。人工智慧、機器學習演算法和雲端基礎平台的整合正在徹底改變傳統的核子醫學實踐，提供更佳的影像品質、更強大的自動化分析能力，並提高病患診療效率。

市場動態

全球核醫軟體市場正受到慢性疾病（尤其是癌症和心血管疾病）日益成長的發病率的驅動，這迫使醫療保健提供者尋求先進的診斷解決方案，以改善患者預後和治療方案。 PET/CT 和 SPECT/CT 系統等混合成像技術的日益普及，需要能夠整合和分析複雜多模態資料的先進軟體平台，從而推動對綜合核醫學軟體解決方案的需求。

人工智慧和機器學習技術的進步顯著增強了軟體功能，實現了自動化影像分析、更高的診斷準確性和更短的解讀時間，吸引了追求營運效率和臨床卓越的醫療機構。然而，市場也面臨著許多限制因素，例如與先進核醫學軟體系統相關的高昂實施成本，這可能會給預算有限的醫療機構帶來巨大壓力，尤其是在成本敏感性仍然是關鍵考慮因素的新興市場。此外，軟體與現有醫院資訊系統整合的複雜性以及法規遵循要求也帶來了實施挑戰，這可能會延遲部署時間表並增加營運開銷。

缺乏能夠有效運用先進軟體平台的熟練核醫專業人員也限制了市場成長，因為培訓和專業知識不足會限制軟體的採用和投資收益。儘管存在這些挑戰，但隨著核醫學在精準醫療和治療診斷學的應用不斷擴大，巨大的機會正在湧現，軟體平台可以支援個人化治療方法和放射性藥物治療監測。人們日益關注基於價值的醫療保健服務模式，這為軟體供應商創造了機會，使他們能夠開發出能夠在診斷效率、患者吞吐量和臨床結果方面實現顯著改進的解決方案，從而證明投資成本的合理性，並促進其在各種醫療保健環境中的市場滲透。

本次調查的主要特點

本報告對全球核醫軟體市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球核醫軟體市場的主要企業。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球核子醫學軟體市場報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過用於分析全球核醫軟體市場的各種策略矩陣更輕鬆地做出決策。

Siemens Healthineers
GE HealthCare
Philips Healthcare
Canon Medical Systems Corporation
Bracco Imaging SpA（via Advanced Accelerator Applications）
Hermes Medical Solutions AB
Segami Corporation
MIM Software Inc.
Mirada Medical Ltd.
INVIA Medical Imaging Solutions
Mediso Medical Imaging Systems
Nuclear Diagnostics AB
Sofie Biosciences Inc.
PMOD Technologies LLC
Xeleris

第13章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第14章參考文獻與調查方法

參考
調查方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI8470

Nuclear Medicine Software Market is estimated to be valued at USD 980.5 Mn in 2025 and is expected to reach USD 1,803.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 980.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.10%	2032 Value Projection:	USD 1,803.9 Mn

The global nuclear medicine software market represents a critical technological backbone supporting the rapidly evolving field of nuclear medicine and molecular imaging. This specialized software encompasses comprehensive solutions designed to facilitate the acquisition, processing, analysis, and management of nuclear medical imaging data, including SPECT, PET, and hybrid imaging modalities.

Nuclear medicine software plays an indispensable role in enhancing diagnostic accuracy, streamlining workflow efficiency, and supporting clinical decision-making across healthcare institutions worldwide. The market encompasses various software categories including image reconstruction software, quantitative analysis tools, reporting systems, and integrated hospital information management platforms.

As healthcare systems increasingly prioritize precision medicine and personalized treatment approaches, nuclear medicine software has emerged as a fundamental component enabling advanced molecular imaging techniques and radiopharmaceutical applications. The integration of artificial intelligence, machine learning algorithms, and cloud-based platforms has revolutionized traditional nuclear medicine practices, offering enhanced image quality, automated analysis capabilities, and improved patient throughput.

Market Dynamics

The global nuclear medicine software market is propelled by several compelling drivers that collectively fuel its robust growth trajectory, with the increasing prevalence of chronic diseases, particularly cancer and cardiovascular disorders, serving as a primary catalyst for market expansion as healthcare providers seek advanced diagnostic solutions to improve patient outcomes and treatment planning. The growing adoption of hybrid imaging technologies, including PET/CT and SPECT/CT systems, necessitates sophisticated software platforms capable of handling complex multi-modal data integration and analysis, thereby driving demand for comprehensive nuclear medicine software solutions.

Technological advancements in artificial intelligence and machine learning are significantly enhancing software capabilities, enabling automated image analysis, improved diagnostic accuracy, and reduced interpretation time, which attracts healthcare institutions seeking operational efficiency and clinical excellence. However, the market faces notable restraints including substantial implementation costs associated with advanced nuclear medicine software systems, which can burden healthcare facilities with limited budgets, particularly in emerging markets where cost-sensitivity remains a critical consideration. Additionally, the complexity of software integration with existing hospital information systems and regulatory compliance requirements create implementation challenges that may delay adoption timelines and increase operational overhead.

The shortage of skilled nuclear medicine professionals capable of effectively utilizing advanced software platforms also constrains market growth, as inadequate training and expertise can limit software utilization and return on investment. Despite these challenges, significant opportunities emerge through the expanding applications of nuclear medicine in precision medicine and theranostics, where software platforms can support personalized treatment approaches and radiopharmaceutical therapy monitoring. The increasing focus on value-based healthcare delivery models creates opportunities for software vendors to develop solutions that demonstrate measurable improvements in diagnostic efficiency, patient throughput, and clinical outcomes, thereby justifying investment costs and driving market penetration across diverse healthcare settings.

Key Features of the Study

This report provides in-depth analysis of the global nuclear medicine software market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nuclear medicine software market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems Corporation, Bracco Imaging S.p.A. (via Advanced Accelerator Applications), Hermes Medical Solutions AB, Segami Corporation, MIM Software Inc., Mirada Medical Ltd., INVIA Medical Imaging Solutions, Mediso Medical Imaging Systems, Nuclear Diagnostics AB, Sofie Biosciences Inc., PMOD Technologies LLC, and Xeleris
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global nuclear medicine software market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nuclear medicine software market

Market Segmentation

Type Insights (Revenue, USD Mn, 2020 - 2032)
- Patient Data Management Software
- Imaging and Visualization Software
- Analysis and Quantification Software
- Clinical Decision Support Software
- Dosimetry Software
- Workflow and Scheduling Software
- Treatment Planning Software
- Others (Artificial Intelligence (AI) and Analytics Software, etc.)
Modality Insights (Revenue, USD Mn, 2020 - 2032)
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Hybrid Imaging Software (PET/CT, SPECT/CT, PET/MRI)
- Others (Planar Scintigraphy, hybrid systems)
Therapeutic Area Insights (Revenue, USD Mn, 2020 - 2032)
- Oncology
- Cardiology
- Neurology
- Endocrinology
- Gastroenterology
- Others (Orthopedics, Infectious disease imaging, etc.)
Deployment Model Insights (Revenue, USD Mn, 2020 - 2032)
- On-Premise
- Cloud-Based
Integration Complexity Insights (Revenue, USD Mn, 2020 - 2032)
- Standalone Software
- Integrated Software Solutions
Pricing Model Insights (Revenue, USD Mn, 2020 - 2032)
- Subscription-based Pricing
- Perpetual License Pricing
- Usage-based Pricing (pay-per-use)
- Freemium or Trial-based Pricing
- Customized or Enterprise Pricing
End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Canon Medical Systems Corporation
- Bracco Imaging S.p.A. (via Advanced Accelerator Applications)
- Hermes Medical Solutions AB
- Segami Corporation
- MIM Software Inc.
- Mirada Medical Ltd.
- INVIA Medical Imaging Solutions
- Mediso Medical Imaging Systems
- Nuclear Diagnostics AB
- Sofie Biosciences Inc.
- PMOD Technologies LLC
- Xeleris

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Nuclear Medicine Software Market, By Type
- Global Nuclear Medicine Software Market, By Modality
- Global Nuclear Medicine Software Market, By Therapeutic Area
- Global Nuclear Medicine Software Market, By Deployment Model
- Global Nuclear Medicine Software Market, By Integration Complexity
- Global Nuclear Medicine Software Market, By Pricing Model
- Global Nuclear Medicine Software Market, By End User
- Global Nuclear Medicine Software Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Nuclear Medicine Software Market, By Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Patient Data Management Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Imaging and Visualization Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Analysis and Quantification Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Clinical Decision Support Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Dosimetry Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Workflow and Scheduling Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Treatment Planning Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Artificial Intelligence (AI) and Analytics Software, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Nuclear Medicine Software Market, By Modality, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Positron Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Single Photon Emission Computed Tomography (SPECT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Hybrid Imaging Software (PET/CT, SPECT/CT, PET/MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Planar Scintigraphy, hybrid systems)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Nuclear Medicine Software Market, By Therapeutic Area, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Orthopedics, Infectious disease imaging, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Nuclear Medicine Software Market, By Deployment Model, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
On-Premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cloud-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Nuclear Medicine Software Market, By Integration Complexity, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Standalone Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Integrated Software Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Nuclear Medicine Software Market, By Pricing Model, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Subscription-based Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Perpetual License Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Usage-based Pricing (pay-per-use)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Freemium or Trial-based Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Customized or Enterprise Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global Nuclear Medicine Software Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

11. Global Nuclear Medicine Software Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Modality, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

12. Competitive Landscape

Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE HealthCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bracco Imaging S.p.A. (via Advanced Accelerator Applications)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hermes Medical Solutions AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Segami Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
MIM Software Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mirada Medical Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
INVIA Medical Imaging Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mediso Medical Imaging Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nuclear Diagnostics AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sofie Biosciences Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PMOD Technologies LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Xeleris
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies